Zimbabwe has rejected a substantial American healthcare agreement valued at $367m (£272m) spanning five years because of Washington's request for confidential biological samples.
This move became public after a internal memorandum dated December was leaked, revealing that President Emmerson Mnangagwa believed the arrangement was "lopsided".
An official spokesperson has since stated that the US was requesting genetic material for scientific study and commercial gain while was not willing to guarantee the resulting advantages from any future treatments.
"We must now begin the difficult and regrettable process of scaling back our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had provided over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has urged more talks to secure a deal suitable to both sides so the nation's vital HIV treatment initiative can proceed.
Broader Implications
This development comes after a comparable situation in neighbouring Kenya, where a court suspended a similar deal with the US after legal challenges were filed about the safety of Kenyans' health data.
After resuming the presidency recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
USAID had overseen aid for the American government, but Trump stated its expenditure was "wasteful" and his administration was seeking direct bilateral agreements to boost transparency and responsibility.
According to reports, 16 African countries have so far signed similar agreements, constituting more than $18.3bn in new funding.
Details of the Declined Agreement
The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership would have delivered immense benefits for Zimbabwean communities, especially the 1.2 million currently on antiretroviral therapy via US-supported initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".
"Zimbabwe was being asked to provide its genetic material and health information indefinitely, without any equivalent assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," he stated.
"Put simply, our nation would provide the raw materials for scientific discovery without any assurance that the resulting innovations would be available to our people if a new health crisis arise."
National Interest and International Frameworks
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining systems previously set up via the global organization.
The spokesperson cited its Pandemic Benefit-Sharing scheme created to deal with future pandemics.
"This framework is designed to ensure that when a country contributes its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We welcome ongoing dialogue with our American counterparts on how future collaboration could be designed in a manner that honours the sovereignty and dignity of each country."
Medical Community Reaction
A leading public health body expressed it understood the official position, but urged that negotiations need to persist considering a large portion of the country's HIV programmes relied on external financing.
"In cases where specific concerns arise, such as those involving data governance or agreement terms, these can frequently be resolved through detailed discussion and negotiated safeguards," it said.
The situation underscores the continuing tensions between receiving crucial foreign assistance and protecting national sovereignty in an ever more interconnected world.